ADR |
adverse drug reaction |
AIDS |
acquired immunodeficiency syndrome |
ARV |
antiretroviral |
ASEAN |
Association of South-East Asian Nations |
BSE |
bovine spongiform encephalopathy |
CAM |
complementary and alternative medicine |
CIOMS |
Council for International Organizations of Medical Sciences |
CJD |
Creutzfeldt-Jakob disease |
CPMP |
Committee for Proprietary Medicinal Products |
CPP |
Certificate of a Pharmaceutical Product |
CRO |
contract research organization |
DRA |
drug regulatory authority |
DT |
diphtheria and tetanus (vaccine) |
EMEA |
European Agency for the Evaluation of Medicines |
EU |
European Union |
GCC |
Gulf Cooperation Council |
GCP |
Good Clinical Practices |
GLP |
Good Laboratory Practices |
GMP |
Good Manufacturing Practices |
GSP |
Good Supplies Practices |
HAV |
hepatitis A virus |
HBV |
hepatitis B virus |
HCV |
hepatitis C virus |
HIV |
human immunodeficiency virus |
HTLV |
human T-cell lymphotropic virus |
ICDRA |
International Conference of Drug Regulatory Authorities |
ICH |
International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use |
MMR |
measles, mumps, rubella (vaccine) |
MOH |
Ministry of Health |
NAT |
nucleic acid testing |
OECD |
Organisation for Economic Co-operation and Development |
OIE |
Office international des Epizooties |
R&D |
research and development |
SPC |
summary of product characteristics |
TCM |
traditional Chinese medicine |
TRIPS |
Trade-Related Intellectual Property Rights (Agreement) |
TSE |
transmissible spongiform encephalopathy |
TT |
tetanus toxoid |
UMC |
Uppsala Monitoring Centre |
WHA |
World Health Assembly |
WHO |
World Health Organization |